XORTX Announces New Clinical Advisory Board Member
CALGARY, Alberta, March 27, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (
Stay updated with breaking news from Charles Edelstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
CALGARY, Alberta, March 27, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (
CALGARY, Alberta, March 27, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANUA WKN: A3UNZ)), a biopharmaceutical company focused on developing
● Xanthine Oxidase Inhibition with XRx-008 Blocks Uric Acid Induced Increasein Total Kidney Weight in Polycystic Kidney Disease ● CALGARY, Alberta, Nov. 03, 2022 -- XORTX... | November 3, 2022
Terms like 'environmentally sustainable', 'eco-friendly', and 'fair trade' have become part of everyday conversations. One thing is clear - the appeal of environmentally and socially responsible products isn't a niche anymore, its popularity cuts across demographics...
CALGARY, Alberta, Jan. 31, 2022 -- XORTX Therapeutics Inc. , a pharmaceutical therapeutics company focused on developing innovative therapies to treat progressive kidney disease, is pleased to... | January 31, 2022